BeiGene completes domicile change, adopts new name and logo
BeOne Medicines Ltd. (HKEX: 6160), formerly known as BeiGene, announced the successful completion of its change of domicile to Switzerland and the adoption of its proposed Swiss Articles, both effective May 27, 2025. As part of the transition, Ernst & Young AG, Switzerland has been appointed as the company's Swiss statutory auditor. Concurrently, the company's English name has been officially changed to BeOne Medicines Ltd., accompanied by a new company logo and website (www.beonemedicines.com). The stock code on the HKEx remains unchanged at "06160". While the English stock short name is expected to change, no arrangements will be made for exchange of existing certificates of securities for new certificates bearing the new English name of the Company. BeOne Medicines I GmbH will serve as the registered office, with Computershare Switzerland Ltd acting as the principal share registrar and transfer office in Switzerland. Existing auditors Ernst & Young LLP (US), Ernst & Young (Hong Kong), and Ernst & Young Hua Ming LLP (China) will continue in their respective roles for SEC, HKEx, and Shanghai Stock Exchange filings.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when BeiGene publishes news
Free account required • Unsubscribe anytime